
1. nucleic acids res. 2020 jan 10;48(1):e2. doi: 10.1093/nar/gkz927.

gene knockdown malaria parasites via non-canonical rnai.

hentzschel f(1)(2)(3), mitesser v(1)(2)(3), fraschka sa(4), krzikalla d(1)(2)(3),
carrillo eh(5), berkhout b(5), bártfai r(4), mueller ak(1)(6), grimm
d(2)(3)(6)(7).

author information: 
(1)heidelberg university hospital, center infectious diseases / parasitology,
im neuenheimer feld 324, 69120 heidelberg, germany.
(2)heidelberg university hospital, center infectious diseases / virology, im 
neuenheimer feld 267, 69120 heidelberg, germany.
(3)bioquant center, heidelberg university, im neuenheimer feld 267, 69120
heidelberg, germany.
(4)radboud university, dept. molecular biology, geert grooteplein 28, 6525 ga 
nijmegen, netherlands.
(5)amsterdam umc, university amsterdam, department medical microbiology,
meibergdreef 15, k3-110, 1105 az amsterdam, netherlands.
(6)german center infection research (dzif), partner site heidelberg.
(7)german center cardiovascular research (dzhk), partner site heidelberg.

the lack endogenous rnai machinery malaria parasite plasmodium hampers 
gene annotation hence antimalarial drug vaccine development. here, we
engineered rodent plasmodium berghei express minimal, non-canonical rnai
machinery solely requires argonaute 2 (ago2) modified short hairpin
rna, so-called agoshrna. using strategy, achieved robust specific
gene knockdown throughout entire parasite life cycle. also successfully
silenced endogenous gene perforin-like protein 2, phenocopying full gene
knockout. transcriptionally restricting ago2 expression liver stage
further enabled us perform stage-specific gene knockout. rnai-competent 
plasmodium lines reported valuable resource loss-of-function
phenotyping many uncharacterized genes plasmodium low high
throughput, without need engineer target gene locus. thereby, new 
strategy transgenic plasmodium lines ultimately benefit discovery of
urgently needed antimalarial drug vaccine candidates. generally, ability 
to render rnai-negative organisms rnai-competent mere introduction two
components, ago2 agoshrna, unique paradigm find broad
applicability species.

© author(s) 2019. published oxford university press behalf nucleic
acids research.

doi: 10.1093/nar/gkz927 
pmcid: pmc7145648
pmid: 31680162  [indexed medline]

